| Nome |
# |
|
Oral corticosteroids dependence and biologic drugs in severe asthma: Myths or facts? a systematic review of real‐world evidence, file e177fbc7-7290-50b0-e053-d805fe0adaee
|
92
|
|
The COPD assessment test and the modified Medical Research Council scale are not equivalent when related to the maximal exercise capacity in COPD patients, file e177fbc7-da7a-50b0-e053-d805fe0adaee
|
30
|
|
An Impairment in Resting and Exertional Breathing Pattern May Occur in Long-Covid Patients with Normal Spirometry and Unexplained Dyspnoea, file 3f14d203-7375-4fee-8f1a-13d8592faac3
|
18
|
|
Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review, file e177fbc7-9bd9-50b0-e053-d805fe0adaee
|
18
|
|
Dexamethasone in patients hospitalized with COVID-19: Whether, when and to whom, file e177fbc7-8010-50b0-e053-d805fe0adaee
|
13
|
|
Sars-cov-2 neutralizing antibodies: A network meta-analysis across vaccines, file e177fbc7-6833-50b0-e053-d805fe0adaee
|
10
|
|
Coronavirus Disease 2019: COSeSco - A Risk Assessment Score to Predict the Risk of Pulmonary Sequelae in COVID-19 Patients, file e177fbc7-6b7e-50b0-e053-d805fe0adaee
|
5
|
|
Detection of Small Airway Dysfunction in Asthmatic Patients by Spirometry and Impulse Oscillometry System, file 1d50dd5f-cbe6-4d04-8acb-ed9933972cc4
|
4
|
|
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study, file e177fbc6-c6f1-50b0-e053-d805fe0adaee
|
4
|
|
Detection of small airway dysfunction in asymptomatic smokers with preserved spirometry: The value of the impulse oscillometry system, file e177fbc7-dc9f-50b0-e053-d805fe0adaee
|
4
|
|
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma, file 10be35d7-f5e7-4b89-ae56-4a126c717eae
|
3
|
|
Long-acting muscarinic antagonists and small airways in asthma: Which link?, file e177fbc7-95b5-50b0-e053-d805fe0adaee
|
3
|
|
Advances in understanding of mechanisms related to increased cardiovascular risk in COPD, file e177fbc7-968e-50b0-e053-d805fe0adaee
|
3
|
|
Brensocatib: Dipeptidyl peptidase 1 (DPP1) inhibitor Treatment of non-cystic fibrosis bronchiectasis, file e177fbc8-1433-50b0-e053-d805fe0adaee
|
3
|
|
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy, file 6e2dbfad-7804-4f2c-b122-5c3c337989fe
|
2
|
|
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score, file 8ea42fba-97ec-4688-81ff-f7cc72bc9ac8
|
2
|
|
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review, file c9d7a919-5e80-4cfb-853a-5fc7e85e12eb
|
2
|
|
Response to letter to the editor. Again on IMPACT: exacerbation after abrupt discontinuation of ICS and pneumonia in fluticasone furoate-containing FDCs, file e177fbc7-9859-50b0-e053-d805fe0adaee
|
2
|
|
Can placebo challenge test (Inducing a “nocebo effect”) be a suitable model to assess stress-induced bronchial obstruction? suggestions from the multidisciplinary working groups “stress-asthma” and “AAIITO regione campania”, file e177fbc7-9aa1-50b0-e053-d805fe0adaee
|
2
|
|
Targeting IL-5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab, file e177fbc7-bcf0-50b0-e053-d805fe0adaee
|
2
|
|
Reply to Han et al.: impact on mortality of triple ICS/LABA/LAMA therapy in a population of COPD patients including also subjects with asthma-like profile, file e177fbc7-d0e9-50b0-e053-d805fe0adaee
|
2
|
|
SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis, file e177fbc7-d15d-50b0-e053-d805fe0adaee
|
2
|
|
Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review, file e177fbc7-d700-50b0-e053-d805fe0adaee
|
2
|
|
Current long-acting muscarinic antagonists for the treatment of asthma, file e177fbc7-e156-50b0-e053-d805fe0adaee
|
2
|
|
Triple therapy in uncontrolled asthma: A network meta-analysis of phase III studies, file e177fbc7-eda2-50b0-e053-d805fe0adaee
|
2
|
|
Ventilation Heterogeneity in Asthma and COPD: The Value of the Poorly Communicating Fraction as the Ratio of Total Lung Capacity to Alveolar Volume, file e177fbc7-f1fa-50b0-e053-d805fe0adaee
|
2
|
|
Step-up and step-down approaches in the treatment of asthma, file e177fbc7-fb02-50b0-e053-d805fe0adaee
|
2
|
|
Editorial overview: Respiratory: Pulmonary pharmacology–The emergence of new treatments in pulmonary medicine is finally providing real therapeutic perspectives, file e177fbc8-06db-50b0-e053-d805fe0adaee
|
2
|
|
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study, file e177fbc8-1808-50b0-e053-d805fe0adaee
|
2
|
|
Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma, file 1b225f46-2ad1-47cc-b1c0-b6b48d2e10b0
|
1
|
|
Inhaled Corticosteroids and COPD: 25 Years Later and We Are Still Not There, file 242cfebc-93ce-4030-af4c-2326f962a287
|
1
|
|
Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis, file 4126e02b-01fa-4c8f-89d2-d801dc72e69d
|
1
|
|
Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings, file 82ff01ba-5c20-4629-aa00-a8c0c806448c
|
1
|
|
Pest sensitization to cockroach, mouse, and rat: An Italian multicenter study, file 9ef5f09e-6329-4a1c-91f0-8bacd0da767a
|
1
|
|
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids?, file e177fbc7-1ad1-50b0-e053-d805fe0adaee
|
1
|
|
Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies, file e177fbc7-95bb-50b0-e053-d805fe0adaee
|
1
|
|
Factors influencing the efficacy of COVID-19 vaccines: A quantitative synthesis of phase III trials, file e177fbc7-961e-50b0-e053-d805fe0adaee
|
1
|
|
Small airways in asthma: from bench-to-bedside, file e177fbc7-9694-50b0-e053-d805fe0adaee
|
1
|
|
Are there pulmonary sequelae in patients recovering from COVID-19?, file e177fbc7-afdb-50b0-e053-d805fe0adaee
|
1
|
|
Advances with glucocorticoids in the treatment of asthma: state of the art, file e177fbc7-b526-50b0-e053-d805fe0adaee
|
1
|
|
Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent, file e177fbc7-ba50-50b0-e053-d805fe0adaee
|
1
|
|
Experimental glucocorticoid receptor agonists for the treatment of asthma: A systematic review, file e177fbc7-bbac-50b0-e053-d805fe0adaee
|
1
|
|
Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination, file e177fbc7-bcec-50b0-e053-d805fe0adaee
|
1
|
|
Pharmacogenomic response of inhaled corticosteroids for the treatment of asthma: Considerations for therapy, file e177fbc7-bcf2-50b0-e053-d805fe0adaee
|
1
|
|
Unmet needs and relationship between general practitioners (GPS) and allergists living in Campania region (Southern Italy), file e177fbc7-c2f5-50b0-e053-d805fe0adaee
|
1
|
|
A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study, file e177fbc7-c42c-50b0-e053-d805fe0adaee
|
1
|
|
Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo, file e177fbc7-c519-50b0-e053-d805fe0adaee
|
1
|
|
Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union, file e177fbc7-ca68-50b0-e053-d805fe0adaee
|
1
|
|
Pharmacology and therapeutics of bronchodilators revisited, file e177fbc7-ca6a-50b0-e053-d805fe0adaee
|
1
|
|
Cardiovascular disease in copd, file e177fbc7-d160-50b0-e053-d805fe0adaee
|
1
|
|
The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review, file e177fbc7-d703-50b0-e053-d805fe0adaee
|
1
|
|
Comparative studies of dual bronchodilation in COPD, file e177fbc7-d8c7-50b0-e053-d805fe0adaee
|
1
|
|
The role of triple therapy in the management of COPD, file e177fbc7-da0d-50b0-e053-d805fe0adaee
|
1
|
|
SMART for the treatment of asthma: A network meta-analysis of real-world evidence, file e177fbc7-da79-50b0-e053-d805fe0adaee
|
1
|
|
Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD), file e177fbc7-da80-50b0-e053-d805fe0adaee
|
1
|
|
Anxiety and depression in adolescents with asthma and in their parents. Is an increased basal cholinergic tone a possible further reason to explain the negative impact on asthma control?, file e177fbc7-dafb-50b0-e053-d805fe0adaee
|
1
|
|
Classes of drugs that target the cellular components of inflammation under clinical development for COPD, file e177fbc7-dc9b-50b0-e053-d805fe0adaee
|
1
|
|
Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways, file e177fbc7-dc9d-50b0-e053-d805fe0adaee
|
1
|
|
The impact of monoclonal antibodies on airway smooth muscle contractility in asthma: A systematic review, file e177fbc7-dd7a-50b0-e053-d805fe0adaee
|
1
|
|
Clinical efficacy of bronchodilators in equine asthma: Looking for minimal important difference, file e177fbc7-de56-50b0-e053-d805fe0adaee
|
1
|
|
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs, file e177fbc7-ef64-50b0-e053-d805fe0adaee
|
1
|
|
Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies, file e177fbc7-ef66-50b0-e053-d805fe0adaee
|
1
|
|
Sex differences in COPD management, file e177fbc7-ef68-50b0-e053-d805fe0adaee
|
1
|
|
Long-acting muscarinic antagonists under investigational to treat chronic obstructive pulmonary disease, file e177fbc7-f2eb-50b0-e053-d805fe0adaee
|
1
|
|
TSLP Inhibitors for Asthma: Current Status and Future Prospects, file e177fbc7-f810-50b0-e053-d805fe0adaee
|
1
|
|
Anthelminthic medicinal plants in veterinary ethnopharmacology: A network meta-analysis following the PRISMA-P and PROSPERO recommendations, file e177fbc7-f812-50b0-e053-d805fe0adaee
|
1
|
|
Multi-walled carbon nanotubes induce airway hyperresponsiveness in human bronchi by stimulating sensory C-fibers and increasing the release of neuronal acetylcholine, file e177fbc7-ffd3-50b0-e053-d805fe0adaee
|
1
|
|
Anxiety/depression and impaired asthma control in adolescents. Is an increased basal cholinergic tone a possible link?, file e177fbc8-0043-50b0-e053-d805fe0adaee
|
1
|
|
The impact of comorbidities on severe asthma, file e177fbc8-0121-50b0-e053-d805fe0adaee
|
1
|
|
Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings, file e177fbc8-03c0-50b0-e053-d805fe0adaee
|
1
|
|
Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review, file e177fbc8-0971-50b0-e053-d805fe0adaee
|
1
|
|
Prospects for severe asthma treatment, file e177fbc8-09db-50b0-e053-d805fe0adaee
|
1
|
|
Mortality in ethos: A question of "power", file e177fbc8-0c11-50b0-e053-d805fe0adaee
|
1
|
|
Protective Effect of Hydroxytyrosol Against Oxidative Stress Induced by the Ochratoxin in Kidney Cells: in vitro and in vivo Study, file e177fbc8-0cdc-50b0-e053-d805fe0adaee
|
1
|
|
Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review, file e177fbc8-0f7c-50b0-e053-d805fe0adaee
|
1
|
| Totale |
286 |